Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Liquid-based cytology: an Australian experience.

Farnsworth A.

Cytopathology. 2003 Apr;14(2):48-52. No abstract available.

PMID:
12713474
2.

Current cervical screening technology considerations: liquid-based cytology and automated screening.

Russell J, Crothers BA, Kaplan KJ, Zahn CM.

Clin Obstet Gynecol. 2005 Mar;48(1):108-19. Review. No abstract available.

PMID:
15725863
3.

Liquid-based cytology - an alternative international view.

Broadstock M.

Cytopathology. 2001 Jun;12(3):141-3. Review. No abstract available.

PMID:
11380554
4.

[New techniques in cytology: liquid milieu and thin slides].

Joris F, Richard J, Tötsch M.

Rev Med Suisse Romande. 1999 Oct;119(10):793-8. Review. French. No abstract available.

PMID:
10582491
5.

[Cervico-uterine cytology in liquid media: procedures and results of the ThinPrep Pap Test].

Dachez R, Monsonego J.

Gynecol Obstet Fertil. 2000 Mar;28(3):250-3. Review. French. No abstract available.

PMID:
10786407
6.

Cervical cancer screening in the 21st century: is it time to retire the PAP smear?

Wright TC Jr.

Clin Obstet Gynecol. 2007 Jun;50(2):313-23. Review.

PMID:
17513921
7.

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J.

Obstet Gynecol. 2008 Jan;111(1):167-77. doi: 10.1097/01.AOG.0000296488.85807.b3. Review.

PMID:
18165406
8.

The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.

Bidus MA, Zahn CM, Maxwell GL, Rodriguez M, Elkas JC, Rose GS.

Clin Obstet Gynecol. 2005 Mar;48(1):127-32. Review. No abstract available.

PMID:
15725865
9.

Cervical cancer screening in the early post vaccine era.

Waxman AG.

Obstet Gynecol Clin North Am. 2008 Dec;35(4):537-48; vii. doi: 10.1016/j.ogc.2008.09.005. Review.

PMID:
19061815
10.

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.

Health Technol Assess. 2004 May;8(20):iii, 1-78. Review.

11.

Quality control and automation in cervical cytology.

Kumar N, Jain S.

J Indian Med Assoc. 2004 Jul;102(7):372, 374, 376 pasim. Review.

PMID:
15717583
12.
13.

[Status of screening tests for cervical cancer and its precancerous lesion].

Zhao FH, Rong SD, Qiao YL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Dec;23(6):638-41. Review. Chinese.

PMID:
12901114
14.

Report disclaimers and informed expectations about Papanicolaou smears: an Australian view.

Mitchell H.

Arch Pathol Lab Med. 1997 Mar;121(3):327-30. Review.

PMID:
9111128
15.

Human papillomavirus testing for primary cervical cancer screening.

Runowicz CD, Garozzo S.

Curr Oncol Rep. 2008 Nov;10(6):533-7. Review.

PMID:
18928670
16.

Overview of the cytology laboratory: specimen processing through diagnosis.

Joste N.

Obstet Gynecol Clin North Am. 2008 Dec;35(4):549-63; viii. doi: 10.1016/j.ogc.2008.09.003. Review.

PMID:
19061816
17.

The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.

Kardos TF.

Cancer. 2004 Dec 25;102(6):334-9. Review. No abstract available.

18.

Cervical screening and human papillomavirus.

Sheary B, Dayan L.

Aust Fam Physician. 2005 Jul;34(7):578-80. Review.

19.

False-negative cervical smears: medico-legal fallacies and suggested remedies.

Slater DN.

Cytopathology. 1998 Jun;9(3):145-54. Review. No abstract available.

PMID:
9638375
20.

Can we change the way we screen?: the ThinPrep Imaging System.

Dawson AE.

Cancer. 2004 Dec 25;102(6):340-4. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk